Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

92
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
92
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

430
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
430
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

138
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
138
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

127
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
127
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

236
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
236

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS Cohort.

Annals of the American Thoracic Society·2026
Same author

Nonparametric Tests for Treatment Effect Leveraging Information on Recurrent and Terminal Events and Physiological Decline.

Statistics in medicine·2026
Same author

Eating Disorders and Parkinson's Disease-1: Comorbidities, Neurobiology, and Family History.

European eating disorders review : the journal of the Eating Disorders Association·2026
Same author

Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Feature-Based Parametric Response Mapping on Thoracic Computed Tomography for Robust Disease Classification in COPD.

medRxiv : the preprint server for health sciences·2026

Related Experiment Video

Updated: Jul 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

τ $$ \tau $$ -Inflated beta regression model for censored recurrent events.

Yizhuo Wang1, Susan Murray1

  • 1Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.

Statistics in Medicine
|February 22, 2024
PubMed
Summary

This study presents a new multivariate zero-inflated beta regression (zero-IBR) model for analyzing censored recurrent event data, accounting for varying susceptibility and event-free periods. The approach offers improved interpretation of patient event times and durations.

Keywords:
expectation-solutiongeneralized estimating equationinflated beta regressionmultiple imputation of censored times-to-eventrecurrent events analysis

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Jul 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Longitudinal Data Analysis

Background:

  • Recurrent event data analysis presents challenges, especially with censored observations.
  • Heterogeneity in event susceptibility and event-free periods complicates modeling.
  • Existing methods may not adequately capture these complexities.

Purpose of the Study:

  • To introduce a novel multivariate zero-inflated beta regression (zero-IBR) model.
  • To analyze censored recurrent event data with a mixture of susceptible and non-susceptible individuals.
  • To provide interpretable outputs for understanding event patterns and durations.

Main Methods:

  • Development of a multivariate zero-IBR model for censored recurrent event data.
  • Application to restructured longitudinal data with overlapping follow-up windows.
  • Integration of multiple imputation (MI) and expectation-solution (ES) for model fitting.
  • Generation of parameter estimates, mean event-free duration estimates, and heat maps.

Main Results:

  • The zero-IBR model effectively handles censored recurrent event data.
  • Provides insights into factors influencing event susceptibility and duration.
  • Demonstrates good statistical performance through simulations.
  • Offers practical application via an example from the Azithromycin for Prevention of COPD Exacerbations Trial.

Conclusions:

  • The proposed zero-IBR modeling approach is a valuable tool for analyzing complex censored recurrent event data.
  • It enhances the understanding of patient heterogeneity in event occurrence and timing.
  • The method provides clinically relevant outputs for patient risk stratification and treatment evaluation.